期刊文献+

CTGF在单侧输尿管梗阻大鼠肾组织中的表达以及活性维生素D_3干预治疗的研究 被引量:4

The expression of CTGF in rat UUO and the intervention study of 1,25(OH)_2D_3
下载PDF
导出
摘要 目的:观察单侧输尿管梗阻大鼠肾脏组织中CTGF的表达以及活性维生素D3(1,25-(OH)2D3)对其表达的影响。探讨1,25-(OH)2D3对大鼠肾间质纤维化的调节作用。方法:随机采用体重180~220g的清洁级Wistar大鼠,雄性,36只,随机分为假手术组(n=12)、UUO模型组(n=12)、活性维生素D3组(n=12)。造膜后活性维生素D3组给予罗盖全(骨化三醇)灌胃(3ng/100g),假手术组及UUO模型组给予等量生理盐水灌胃。给药后第14天,28天分批(n=6)处死,取造膜侧肾脏。用HE染色及Masson染色方法观察肾脏组织纤维化程度,用免疫组化法测定结缔组织生长因子(CTGF)在各组大鼠造膜侧肾脏的表达情况。结果:与假手术组比较,UUO模型组大鼠的肾脏组织中CTGF的表达有显著增高(P〈0.05),而在活性维生素D3治疗组中,CTGF的表达低于UUO模型组(P〈0.05),肾间质纤维化程度也明显小于模型组(P〈0.01)。结论:CTGF在UUO大鼠肾脏中表达明显增高,1,25(OH)2D3能有效抑制UUO大鼠肾脏组织CTGF的表达,从而减轻UUO大鼠肾脏组织纤维化程度。 Objective: To observe the expression of connective tissue growth tactor/(CTCF) in rat mclneys with unilateral ureteral obstruction, and explore the role of 1,25- (OH)zD3 on Renal interstitial fibrosis. Meth- ods : Thirty-- three Wistar rats were randomly divided into sham-- operation group (n = 12) , UUO model group (model group, n = 12) and Treatment with 1,25 -- (OH2D3 group (n = 12). Treatment with 1,25-- OH)2D3 group was treated with Rocahrol (calcitriol) (3ng/100g) by the gastric perfusion. Sham--operation group and UUO model group were given the same amount of normal saline. Rats were sacrificed 14 and 28 days after op- eration (after model establishment for model group)(n= 6),and the renal tissues of the operated side(obstruct- ed side for model group)were obtained. The renal fibrosis was observed with HE staining method and Masson staining method. The expression of CTGF in rat kidney of each group was determined by immunohistochemical method. Results:Compared with the sham group, the expression of CTGF in the kidney ti: sue in UUO model group rats was significantly higher (P 〈 0.0S), while the expression of CTGF in the treatment group is lower than the UUO model group (P 〈 0.05), renal interstitial fibrosisdegree significantly less than model group (P 〈 0. 01). Conclusion:CTGF was significantly increased in UUO rat kidney. 1,25 (OH)2D3 can effectively inhibit the expression of CTGF in UUO rat kidneys,thereby reduce the fibrosis of UUO rat kidney.
出处 《黑龙江医药科学》 2012年第4期22-23,共2页 Heilongjiang Medicine and Pharmacy
基金 黑龙江省卫生厅科研项目 编号:2010-500 佳木斯大学科学计划项目 编号:S2010-073
关键词 肾间质纤维化 结缔组织生长因子 活性维生素D3 renal interstitial fibrosis CTGF 1,2 5 (OH) 2D3
  • 相关文献

参考文献9

  • 1Brigstock DR. The connect ive tissue growth fact or/cyst einerich 61/nephroblastoma overexpressed ( CCN ) family [J] Endocr Rev, 1999,20:189.
  • 2]Bradham DM, Igarashi A, Potter RL,et al. Connective tissue growth factor a cyst einerich mitogen secret ed hy human vascular endothe- lial cells is reated to the SRCinduced immediate early gene product CEF210[J]. J Cell Biol, 1991,114 : 1285.
  • 3Letterio JJ ,Bottinger EP. TGF2bet a knockout and dominant2negat ire receptor transgenic mice[J ]. Miner Electrolyte Metab, 1998,24 : 161.
  • 4Andress DL. Vitamin D in chronic kidney disease:A systemic role for selective vitamin D receptor activation[J]. Kidney Int, 2006,69 : 33-43.
  • 5Tan X,Li Y,Liu Y. Paricalcitol attenuates renal interst it ial fib ro- sis in obstructive nephropathy [J]. J Am See Neph rol, 2006, 17 (12) : 3382-3393.
  • 6Suga H,Teraoka S,Oka K,et al. Yamauchi S,Margolin S. Preven- tive effect of pirfenidone against experimentalsclerosing peritonitis in rats[J]. Exp Toxicol Patho, 1995,47 : 287-292.
  • 7Duce B, Miric G, Mirkovic S, et al. Reverl of cardiac fibrosis by pirfenidone[J]. Naunyn Schmiedebergs Arch Pharmacol, 1998,358 (supp[2) 36-47.
  • 8Grot endorst GR. Connective tissue growth factor: a mediator of TGFbeta action on fibroblasts[J]. Cytokine Growth Factor Rev, 1997,8:171.
  • 9Kothapall i D, Grot endorst GR. CTGF modulates cell cycle progres- sion in cAMParrest ed NRK f ibroblasts[J]. J Cell Physiol, 2000, 182:119.

同被引文献29

  • 1韩敏,徐钢,曾锐,刘蔚.β-连环素酪氨酸磷酸化调控E-钙黏蛋白表达参与转化生长因子β1诱导的人肾小管上皮细胞转分化[J].中华肾脏病杂志,2006,22(8):494-498. 被引量:21
  • 2Solez K, Axelsen RA, Benedi RH, et al. International standardiza- tion of criteria for the histologic diagnosis of renal allograft rejec- tion: the Banff working classification of kidney transplant pathology [J]. Kidney Int, 1993, 44:411 - 422.
  • 3Hironoby T,Hironobu MD. Pathogenesis of fibrosis : role of TGF --and CT3F[J] Current Opinion , 2002, 14 (6) : 681 - 685.
  • 4Qi W,Chen X,Poronnik P,et al. The renal cortical fibroblast in re- nal tubulointerstitial fibrosis[J], lnt J Biochem Cell Biol, 2006: 38 (1).'1 -5.
  • 5Badid C, Mounier N, Costa AM. Desmouliere A: Role of myofi- broblasts during normal tissue repair and excessive scarring: Inter- est of their assessment in nephropathies[J]. Histol Histopathol, 1997, 15:926- 931.
  • 6Makibayashi K, Tatematsu M, Hirata M, et al. A Vitamin Dana- log ameliorates glomerular injury on ratglomeralonephritis[J]. Am J Pathol, 200l, 58(5)11733-1741.
  • 7Li YC, Kong J, Wei M, et al. 1,25 - Dihydroxyvitamin D (3) isa negative endocrine regulator of the rennin--angiotensinsystem[J]. J Clin Invest, 2002,110 : 229 - 238.
  • 8Dussaule JC,Chatziantoniou C.Reversal of renal disease:is it enough to inhibit the action of angiotensin Ⅱ[J].Cell Death Differ,2007,14 (7):1343-1349.
  • 9Sodhi CP,BatlleD,SahaiA.Osteopontinmediateshypoxia-induced proliferation of cultured mesangial cell[J].Kidney Int,2000,58(2):691-700.
  • 10EndlichN,Sunohara M,NietfeldW,et al.Analysis of differen-tial gene expression in stretched podocytes:osteopontin en-hancesadaptationof podocytes to mechanical stress[J].FASEBJ,2002,16 (3):1850-1852.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部